Key Takeaways
- Unitree’s stock plummeted 45% following a spectacular 460% jump during its Shanghai market debut
- Market capitalization peaked at $66 billion before shedding more than 200 billion yuan within days
- Q1 adjusted earnings plunged 53% amid rising expenses and scarce commercial contracts
- The dramatic collapse has intensified criticism of China’s IPO valuation mechanisms
- Market observers point to a disconnect between robotics enthusiasm and actual market readiness
The Hangzhou-headquartered humanoid robotics company Unitree has emerged as the newest example of speculative excess in China’s technology investment landscape. The firm’s shares have tumbled approximately 45% from their peak of 1,100 yuan reached shortly after trading commenced on August 19 in Shanghai.
Trading concluded Monday with shares at 603.08 yuan, a significant drop from the 845 yuan closing price recorded on day one. Despite the dramatic downturn, the stock continues to trade around four times its initial offering price of 150.80 yuan.
The listing day delivered remarkable statistics. Close to 9.8 million individual investor accounts vied for approximately 9.7 million shares available for purchase. Trading began 629% higher than the offer price and concluded the inaugural session with a 460% gain, temporarily elevating the company’s worth to roughly 445 billion yuanāequivalent to $66 billion.
By Monday’s market close, that valuation had contracted to approximately 244 billion yuan, representing a destruction of wealth exceeding 200 billion yuan in less than seven days.
Financial Reality Contradicts Market Enthusiasm
The steep decline follows closer examination of Unitree’s financial performance. While revenues expanded more than four times to reach 1.7 billion yuan in 2025, and the company achieved profitability before going public, recent results tell a different story.
More current data reveals challenges. First-quarter 2026 adjusted net profit contracted 53% to approximately 40 million yuan as operating costs escalated.
Company founder Wang Xingxing publicly stated at the World Robot Conference that humanoid robots have not achieved the maturity required for widespread industrial implementation. He noted these machines continue to underperform human workers at routine tasks and lack the flexibility to transition effectively between different roles.
Prior to the public offering, HSBC analysts cautioned that the recent uptick in humanoid robot deliveries might prove difficult to maintain absent substantial advances in artificial intelligence technology.
Regulatory Framework Faces Scrutiny
The extreme volatility has reignited debate surrounding China’s approach to pricing initial public offerings. Government regulators maintain substantial influence over approval processes and price-setting mechanisms, while the STAR Market’s constrained initial share availability can generate acute supply shortages when investor appetite runs high.
Limited short-selling capabilities leave doubters with minimal options to counteract overvalued debuts.
Venture capital investor Abraham Zhang criticized the framework for enabling major stakeholders to exit at excessive valuations while individual investors bear the financial consequences. “Those who secured IPO allocations departed victorious,” he observed.
A retail trader who suffered losses commented online that advancing Chinese technological innovation “should not be financed through retail investor suffering.”
This pattern extends beyond Unitree. CXMT, a DRAM memory chip manufacturer, experienced a 466% surge during its Shanghai launch last month before encountering comparable downward pressure.
Notwithstanding the selloff, Unitree delivered over 5,500 humanoid robots throughout 2025, positioning it among the globe’s leading producers. Nomura analysts suggest its aggressive product innovation cycle provides competitive advantages as the sector evolves.





